The Federal Trade Commission has finally approved the joint venture of Novartis AG (ADR) (NYSE:NVS) and GlaxoSmithKline Plc (ADR) (NYSE:GSK) in consumer health products, and Novartis has agreed to divest its Habitrol line of nicotine patches.
{iframe}http://www.bidnessetc.com/33001-ftc-approves-novartisgsk-deal-former-asked-to-divest-nicotine-patch-busines/{/iframe}